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ABSTRACT
Khan, Sanjoy Kumar, Ph.D. The University of Memphis. December 2012.
Genetic and Biochemical Dissection of Differential Functions of Cryptochrome 1
and 2 in the Mammalian Circadian Clock. Major Professor: Dr. Andrew C. Liu.
Circadian clocks in mammals are based on a negative feedback loop in
which transcriptional repression by the Cryptochromes, CRY1 and CRY2, lies at
the heart of the mechanism. Despite similarities in their sequence, domain
structure and biochemical activity, they play distinct roles in the mammalian clock
function. However, detailed biochemical studies have not been straightforward
and function of Cryptochrome (Cry) has not been examined in real clock cells
using kinetic measurements. In this study, we demonstrate, through cell-based
genetic complementation and real-time molecular recording, that Cry1 alone is
able to maintain cell-autonomous circadian rhythms, while Cry2 cannot. Using
this novel functional assay, we identify a Cryptochrome differentiating α-helical
domain within the photolyase homology region (PHR) of CRY1 protein,
designated as CRY1-PHR(313-426), that is required for clock function and
distinguishes CRY1 from CRY2. Further, in contrast to speculation, we
demonstrate that the divergent carboxyl-terminal tail domain (CTD) is
dispensable for circadian clock function, but it serves to modulate rhythm
amplitude and period length. Finally, we identify the biochemical basis of their
distinct function; CRY1 is a much more potent repressor of BMAL1/CLOCK
transcriptional activity than CRY2, and the strength of repression by various
forms of CRY proteins significantly correlates with rhythm amplitude. Taken
together, our results demonstrate that the CRY1-PHR(313-426), not the
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divergent CTD, is critical for clock function. These findings provide novel insights
into the evolution of the diverse functions of the photolyase/cryptochrome family
of flavoproteins and offer new opportunities for mechanistic studies of CRY
function.
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INTRODUCTION
Rotation of the earth around its axis and around the sun brings about daily
and seasonal changes in our natural environment. To cope with these changes in
the environment, natural selection has favored the evolution of endogenous timekeeping system or biological clocks. From unicellular organisms like
cyanobacteria to complex organisms like fungi, plants, insects and vertebrates,
including humans, endogenous clocks with a period length of ~24 hr have been
evolved to regulate different physiology and behavior according to time of the
day. These clocks are thought to provide an adaptive advantage by enabling
organisms to anticipate daily environmental changes for their survival by enabling
them to tailor their behavior and physiology to the specific time of the day (1,2).
In mammals, daily behavioral and physiological rhythms such as sleep/wake
cycle, hormone production, body temperature, blood pressure, metabolism etc.
are driven by their endogenous time-keeping system (3,4). Genetic and
environmental factors that affect this internal time-keeping system can cause
clock-related disorders such as sleep disorders (delayed or advanced sleep
phase syndrome), metabolic disorders, and cancer (5-7).
This internal time-keeping system is synchronized everyday with the lightdark cycle of the natural environment. This daily synchronization allows
organisms to keep track of not only the daily cycles of day and night but also the
change in duration of light-dark periods. This daily time-keeping system is known
as circadian clock. (In Latin, circa means about, and diem means day; and
circadian means about a day.) Interestingly, the circadian time-keeping system
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that carries out daily adjustment is also used as a seasonal timer. The external
cues are so-called “zeitgeber” or time-giver. For almost all living organisms on
earth, light is the primary zeitgeber to the clock. As a result, specific
photoreception and transduction mechanisms have evolved in these organisms
(8,9). However, circadian clocks are self-sustainable oscillators; they run even in
the absence of external zeitgebers. Circadian clocks are also temperature
compensated (10); therefore, organisms can maintain their circadian rhythms
over a range of environmental temperatures.
My dissertation focuses on mammalian circadian clocks. Here, I will first
discuss the mammalian circadian time-keeping system followed by its underlying
molecular mechanisms. Then, I will present the most current understanding of
the structure and function of cryptochromes, CRY1 and CRY2, the core clock
components of the mammalian clock. I will present in vivo and in vitro genetic
evidences that suggested their differential functions in the clock mechanism.
Prior to my study, the underlying basis of their differential functions was elusive.
My dissertation aims at the understanding of the genetic and biochemical basis
of the differential functions of CRY 1 and 2.
Hierarchy of Mammalian Circadian Time-keeping System–The
mammalian circadian time-keeping system consists of mainly three components;
input signals (environmental cues), a multi-oscillator network (circadian rhythm
generator) and output signals (circadian overt rhythms) (11). The multi-oscillator
network is a hierarchical system in mammals. At the organismal level, the
suprachiasmatic nucleus (SCN) of the anterior hypothalamus is the master
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oscillator that regulates circadian behavioral activities. Ablation of SCN resulted
in complete loss of circadian rhythms whereas transplantation of intact SCN from
a wild type animal to a mutant resulted in reestablishment of circadian rhythms
(12,13). Therefore, SCN is accepted as the master oscillator.
The molecular clock machinery of this master oscillator is contained in
individual neurons. Intercellular coupling among these neurons serves to
synchronize their rhythms and also confers system robustness to the SCN, a
special attribute of the SCN network (14). Remarkably, cell- or tissueautonomous peripheral oscillators (slave oscillators) are present in all the tissues
of the body. The presence of peripheral oscillators was demonstrated by
rhythmic gene expression in different tissue explants and in cultured fibroblasts
(15,16). Unlike SCN, these peripheral oscillators cannot be entrained by light
cues; rather, the SCN, the master clock, functions to synchronize all the
peripheral slave oscillators throughout the body (17,18). The SCN synchronizes
peripheral oscillators using systemic, neuronal and humoral routes (19). Upon
synchronization, these peripheral oscillators generate overt circadian rhythms
such as sleep-wake cycle, rhythms in hormone secretion, blood pressure,
metabolism etc as their output (Fig. 1). Genetic studies have demonstrated that
the molecular composition of the timing mechanism in the SCN clock and
peripheral clocks is very similar (14,20). Thus, cultured cells are the functional
units for rhythm generation and maintenance and provide an experimentally
more tractable in vitro system for mechanistic studies and gene discovery related
to circadian clocks.
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Transcriptional Feedback Loops Underlie The Molecular Clock
Mechanism–Circadian rhythms are emanated ultimately from the cellautonomous clocks. In general, all circadian systems described so far are
composed of an autoregulatory negative feedback loop that contains both
positive and negative transcriptional components (17,21-23). In the mammalian
system, the molecular clock consists of two inter-connected
transcription/translation feedback loops. The positive elements (activators) in the
core loop include the two basic helix-loop-helix (bHLH)/PAS domain-containing
transcription factors, BMAL1 (brain and muscle ARNT-like protein or ARNTL1)
and CLOCK (circadian locomotor output cycle kaput). They form a heterodimer
which binds to the E-box element within the promoter region and activates the
transcription of many genes including Periods (Per1, 2 and 3), Cyrptochromes
(Cry 1 and 2) and Rev-Erbα. The repressors PER and CRY translocate to the
nucleus in which they interact with BMAL1/CLOCK heterodimer and inhibit their
own transcription.
In a separate auxiliary loop (interconnected with major loop), circadian
oscillation of Bmal1 expression is regulated by a balanced act of transcription
activator ROR-α and repressor Rev-Erb-α (23) (Fig. 2). Thus, in the autoregulatory negative feedback loops, positive components drive the expression of
negative components, that in turn repress the activity of the activators and
therefore the expression of the repressors; this regulation thus constitutes the
second negative feedback loop. Post-translational mechanisms play critical roles
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FIGURE 1. Hierarchy of mammalian circadian time-keeping system. Daily
oscillation of light/dark cycle is directly perceived by eyes. The light cue is then
transported through retinohypothalamic tract (RHT) to the master oscillator
suprachiasmatic nucleus (SCN) located in the anterior hypothalamus. The SCN
acts as the master oscillator, which is entrained by the light/dark cycle and
generates concerted rhythms in its output. The output signals from SCN entrain
the peripheral oscillators located in different organs in the body. Upon
synchronization, the peripheral oscillators generate overt rhythms in different
physiology and metabolisms of the organism. The external cues for entrainment,
the master and slave oscillators, and the output rhythms are the three basic
components of mammalian circadian time-keeping system.
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in regulating protein turnover of the key components, thus temporally separating
the positive and negative components and preventing the clock from reaching
equilibrium, thereby causing rhythmic gene expression with a period length of
~24 hr (24-27).
Circadian rhythms in all living organisms consist of several basic
characteristics and parameters (Fig. 3). Circadian rhythms are entrainable to
environmental cues known as zeitgebers. The most dominating zeitgeber for
most of the organisms is the daily light:dark (LD) cycle. Circadian rhythms are
self-sustainable; they persist even in absence of any external cues and these
rhythms are known as free-running rhythms. In mammals, free-running rhythms
are generally referred to as behavioral rhythms under constant darkness.
Similarly, cell- or tissue-autonomous rhythms are also observed when they are
cultured under constant conditions. The phase of a circadian rhythm is defined as
the timing of peaks relative to a fixed event (e.g., beginning of the night phase).
The time-lapse between two phase reference points (e.g., two peaks) is known
as period length of the rhythms. The difference between the peak (or trough) and
the mean value is called amplitude (Fig. 3).
In mammalian clocks, the transcriptional mechanism is regulated by at
least three DNA elements; morning time element E-box/E’-box (18,28-30), daytime element D-box (18,31), and night-time element RRE (18,32-34). E-box/E’box-regulated transcription is mediated by at least 11 transcription factors,
including four bHLH-PAS domain containing transcription activators CLOCK,
NPAS2, BMAL1 and BMAL2 (35-38), two transcription repressors, CRY1 and
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FIGURE 2. Mammalian circadian clock network consisting of two
interlocking negative feedback loops. The heterodimer BMAL1/CLOCK acts
as transcription activators by interacting with the E-box located in the promoter
region of genes including Per and Cry. PER and CRY in turn suppress their own
transcription by inhibiting BMAL1/CLOCK transcriptional activity. Upon
phosphorylation by CK1, PER is targeted for proteosomal degradation which
results in starting of next cycle. Assisting this core loop, DBP and E4BP4
regulate Per expression by acting as transcriptional activator and repressor of Dbox element, respectively. In the interconnected Bmal1 feedback loop, rhythmic
expression of Bmal1 is regulated by the action of transcriptional activator ROR
and repressor REV-ERB on circadian element, RRE. These two interlocking
loops together regulate circadian rhythms of additional genes with additional
phases. Adapted with modifications from Doi, M. 2012 (39).
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CRY2 (24) and three period proteins, PER1, PER2 and PER3 (40-42). The Dbox-mediated transcription is regulated by four bZIP transcription factors, DBP,
HLF, and TEF as activators, and E4BP4 as a repressor (43-46). The RREmediated transcription is controlled by five orphan nuclear receptors, REV-ERBα
and REV-ERBβ repressors (also known as NR1D1 and NR1D2) and ROR-α,
ROR-β and ROR-γ activators (23,33,34). All these circadian elements, in
combination or individually, regulate the expression phases of the clock genes
resulting in a complex clock network which generates circadian rhythms in
mammals.
Among all clock genes, interestingly, Cry1 has a unique expression
pattern that peaks at the evening phase (~CT16-20), which is distinct from day or
night phase and is not accounted for by any one of the circadian elements. Cry1
peak expression is at an intermediate phase in between D-box- and RREregulated gene expression (18,34). The Cry1 expression pattern (i.e., rhythm and
phase) plays an important role in the core regulatory loop of the circadian clock
network.
Previous studies identified an E/E’-box within Cry1’s regulatory region
(18,47) and two RREs within the first intron of the Cry1 gene. Recently we
identified additional D-boxes in the promoter region of Cry1 and showed that a
synthetic promoter contacting all three types of circadian elements conferred
evening-time expression of a luciferase reporter, likely through combinatorial
regulation. Further, this delayed Cry1 expression was required for circadian clock
function (48). Among the PERs and CRYs in mammals, CRYs are much more
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FIGURE 3. Parameters of circadian rhythms. Circadian rhythms in all living
organisms are entrained by LD cycle in the natural environment. They exhibit
free-running rhythms under constant darkness. The phase is the timing of peaks
with relative to a fixed event (e.g. beginning of dark phase). The time lapse
between two peaks is called period length of the rhythm. The difference between
peak (or trough) and midline is called amplitude.
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potent repressors than PERs (24); however, the underlying mechanism of
repression by the CRYs is still largely elusive.
Cryptochromes: origin and classification– CRYs belong to the photolyase/
cryptochrome super-family of flavoproteins (49). These two classes of
flavoproteins use the same two cofactors, flavin and pterin
methenyltetrahydofolate (MTHF), to carry out distinct biological functions (50,51).
Photolyases are DNA repair enzymes that revert UV-induced photoproduct inside
DNA – cyclobutane-pyrimidine-dimers (CPD) and (6-4) pryrimidine-pyrimidone
photolesions – back to the original pyrimidine-pyrimidine dinucleotides to
maintain genetic integrity of the organisms (52). Though there are controversies
about the evolution of the cryptochromes, it is largely accepted that they are
evolved from photolyases.
Cryptochrome was first discovered in Arabidopsis thaliana in 1993 when
the HY4 gene was isolated (53). Arabidopsis seedlings that grow under light
exhibit different photomorphogenic responses from those that grow under dark,
such as inhibited stem elongation and stimulated leaf expansion. Seedlings
under light grow significantly shorter stems (hypocotyl) than those grown in
darkness; this response is governed by blue (400-490 nm), red (600-700 nm)
and far-red (700-750 nm) light. Genetic screen for hypocotyl mutants identified
several mutants (hy) in which mutations result in inability to respond to one or
more of these monochromatic lights (54). Among all the mutants, the hy4 mutant
lost its ability to respond to blue light selectively, indicating a disruption of a bluelight photoreceptor or a component in blue-light signaling pathway.
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Subsequently, cloning of the HY4 gene revealed significant sequence homology
to E.coli photolyase (55). However, unlike photolyases, the recombinant protein
did not display any DNA repair activity (56,57). These biochemical studies of Hy
led to identification of the first member in a novel class of blue-light
photoreceptors. Since they share a high percentage of sequence homology to
photolyase yet without DNA repair activity, they were named accordingly
cryptochromes (CRY) ever since. The second Cryptochrome gene, Cry2, was
cloned in 1996 and was shown to have effect only under dim light conditions
(58,59).
Many CRYs in other species have since been discovered. On the basis of
their sequence similarities, CRYs can be classified into three categories; plant
cryptochromes, animal cryptochromes and cryptochrome-DASH (DASH=
Drosophila, Arabidopsis, Synechocystis, Homo) reviewed by (60).
Plant Cryptochrome– Since cryptochrome was discovered first in
Arabidopsis thaliana, it has been the most used plant species for studying
cryptochrome function in plants. Arabidopsis cryptochromes (Cry1 and 2) have
the greatest effect on the photomorphogenic response. They have
complementary functions in regulating photmorphogenic responses, as Cry1
mainly functions under bright light and Cry2 functions under dim light conditions.
Arabidopsis cryptochromes exert their photomorphogenic effects by regulating
gene expression. Approximately, one-third of Arabidopsis genes have light
dependent change in their expression. It has been shown that cryptochromes
acting as blue-light photoreceptors in Arabidopsis regulate light-dependent gene
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expression and thus, photomorphogenic responses (61,62). Regulation of lightdependent gene expression by cryptochrome is thought to be mediated by its
direct interaction with E3 ubiquitin ligase COP1. In the dark, COP1, a zinc-finger
protein, degrades bZIP transcription factors including HY5, STO, STH, and HFR
(63-65). In the presence of light, COP1 is translocated out of the nucleus and
thus its ligase activity on transcription factors is inhibited (64,66-68), thus
allowing for accumulation of transcription factors and subsequent regulation of
gene expression. CRY1 and CRY2 have been shown to directly interact with
COP1 through their C-terminal tail domain in a light-dependent fashion (69,70).
Therefore, light-dependent, CRY-mediated nuclear exclusion of COP1 (66-68) is
the key for photomorphogenic effect of cryptochromes in plants.
However, many of the cryptochrome-regulated genes in Arabidopsis are
also regulated by phytochromes, a red-light photopigment. Therefore,
cryptochromes function in conjunction with phytochromes to regulate
photomorphogenic responses in plants such as growth and development,
photoperiodic flowering, and circadian clock entrainment (71).
Animal Cryptochromes– Animal cryptochromes possess more sequence
similarity with (6-4) photolyases than with plant cryptochromes (50). The first
mammalian cryptochrome was identified when a photolyase ortholog was
identified as an expressed sequence tag (EST) in the human genome database
(72). A second photolyase ortholog was subsequently identified (73). It was
further shown that these two homologs do not possess any photolyase activity.
Therefore, they were classified as cryptochromes (73). Thereafter, cryptochrome
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homologs were identified in many other animals, including insects, amphibians,
fish, birds, and other mammals (74).
Among all animal cryptochromes, Drosophila cryptochrome represents
one of the best characterized animal cryptochromes thus far. Fly cryptochrome
was discovered in a genetic screen for circadian rhythm mutants in Drosophila
(75). In their screen, Stanewsky and his colleagues identified a loss-of-function
mutant Cryb or Crybaby that was caused by a substitution mutation of Asp →Asn at
amino acid 410. Cryb was shown to have lost its sensitivity to phase-shifting light
pulses in the dark even though their molecular clock was still functional,
indicating the loss of photoentrainment of the clock (75). Interestingly, the Cryb
mutant was shown to maintain normal circadian rhythms under constant light
which would otherwise results in arrhythmia in wild-type flies (75,76), suggesting
a role of cryptochrome as a photoreceptor required for circadian clock
entrainment in flies. One important aspect of the Drosophila time-keeping system
is that almost every cell in their body is light sensitive, and clocks in these cells
can be reset by light cues (77,78). The photo-entrainment of fly clocks has been
shown to be mediated via interaction of cryptochrome with Timelss (TIM).
Drosophila CRY (dCRY) was found to interact with TIM only in presence of light
(79,80). The resetting of the clock most likely occurs through cryptochromemediated induction of light-dependent, ubiquitin-mediated degradation of TIM
(81-83). TIM degradation then causes degradation of PER, the repressor of
CYCLE/CLOCK transcriptional activator activity, and thus allows for transcription
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to occur (84). Therefore, light dependent degradation of TIM by dCRY is the key
for photo-entrainment of the fly clock.
Cryptochrome-DASH– Recently, a new class of cryptochromes has been
discovered, first in the cyanobacterium Synechocystis sp. PCC 6803 (85,86) and
subsequently in many different species such as plants (87), prokaryotes (88),
aquatic vertebrates and fungi (89). This class of cryptochromes is called DASH
as it bears more homology to Drosophila, Arabidopsis, Synechocystis and
Human than bacterial photolyases (90). Initial characterization of CRY-DASH
demonstrated no photoreception activity for this class of proteins, which led to its
classification as a cryptochrome. More recently, CRY-DASH has been shown to
be single strand-specific CPD-photolyases (91,92).
Cryptochrome Structure and Functions– Photolyases are DNA repair
enzymes that use blue light to repair UV-induced DNA damage in bacteria by
removing adjacent pyrimidine dimers from DNA and thus maintain the genetic
integrity. Two major types of pyrimidine dimers are formed; cyclobutane
pyrimidine dimer (CPD) and (6-4) pyrimidine-pyrimidone dimer. CPD photolyses
repair cyclobutane pyrimidine dimers and 6-4 photolyses repair (6-4) pyrimidinepyrimidone dimers. These two types of photolyases, along with the
cryptochromes, constitute the photolyase/ cryptochrome superfamily.
In general, the crystal structure of photolyases contains two modular
domains: an amino-terminal α/β domain and a carboxy-terminal α-helical domain
(Fig. 4). This family of proteins contains two non-covalently bound cofactors/
chromophores in their structures. The catalytic chromophore FAD binds within
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the α-helical domain whereas pterin (MTHF) binds at the interface between these
two domains. The pterin harvests energy from light and transfers the excitation
energy to FAD, which subsequently transfers an electron to repair damaged DNA
(93). The crystal structure of the PHR domain of Arabidopsis CRY1 (AtCRY1)
was determined in 2004 in which a non-covalently bound FAD cofactor is present
within the PHR (94). Recently, the crystal structure of Drosophila Cryptochrome
has been determined that contained the FAD cofactor (95). However, so far
there are no crystal structures available for mammalian cryptochromes.
Thus, cryptochromes also seem to utilize the same two (FAD and MTHF)
chromophores, though formal proof of the presence of MTHF is lacking for
cryptochromes. The main structural difference between cryptochromes and
photolyases lies in the carboxy terminal tail domain (CTD); while all the CRYs
contain an extended CTD, photolyases lack this tail region. The extended CTDs
of cryptochromes range from 30 to 350 amino acids in length (96), and their
sequences have diverged significantly across species as well as between
mammalian CRY1 and CRY2.
Biochemical and biophysical studies demonstrated that the CTDs of
cryptochromes are highly unstructured when expressed alone (97,98). However,
they form a rigid conformation by interacting with the PHR domain (71,97). Even
though mouse CRY1 and CRY2 share 70-80% sequence identity/similarity, the
least conserved domain is located at the CTD (Fig. 5). Since there is no crystal
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FIGURE 4. Typical structural features of photolyases. N-terminal α/β domain
is shown in blue and C-terminal α-helical domain in yellow. These two domains
together are called photolyase homology region (PHR) and connected by an
inter-domain loop (green). The binding pockets for two cofactors, FAD and Pterin
lie within the photolyase homology region. Adapted with modifications from Lin
and Todo, 2005 (60).
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structure of mammalian cryptochromes available, it is difficult to understand the
structure-function relationship for this variable CTD of cryptochromes. It would be
of immense interest to identify the functional significance of this variable carboxyterminal domain which could provide clues to the differential functions of
cryptochromes.
In spite of having high sequence and domain similarities, cryptochromes
function differently across species. They act as photoreceptors to regulate growth
and development in plants (53,99) or to reset or entrain the circadian clocks in
plants and insects including Drosophila (75,100,101). Evidences seem to
suggest that the Drosophila cryptochrome (dCRY) may be involved in core clock
function in the peripheral tissues (75,101). Intriguingly, however, CRYs in
mammals do not have photolyase activity and do not function as photoreceptors
(102-105); rather, they function as potent repressors that inhibit E-box-mediated
transcription of clock controlled genes. Therefore, they are core clock
components in mammals (25,106-108).
Differential Functions of Mammalian Cryptochromes: Loss-of-Function
Studies– The Drosophila dPER is a potent repressor and required for regulation
of circadian rhythms (109). Mutations at the Per locus can alter clock function:
compared to WT, perS and perL mutants show shorter and longer periods,
respectively, while per0 null mutants are arrhythmic under free-running conditions
(110,111). In contrast, the potent repressors in the mammalian clock are CRYs,
not PERs (24). Although both CRYs are repressors, experimental data suggest
that CRY1 and CRY2 have overlapping but differential functions in the clock
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mechanism. It has been shown that Cry1 and Cry2 play opposite roles in
regulating animal behavior: Cry1–/– and Cry2–/– mice display shorter and longer
free-running period length of locomotor activity rhythms, respectively, compared
to wild type mice (25,108). Similarly, SCN explants from Cry1–/– mice exhibit
shorter period length than wild type, whereas Cry2–/– SCN explants exhibit longer
period (14).
Interestingly, Cry1 and Cry2 play distinct roles in generating and
maintaining cell-autonomous circadian rhythms. For example, dissociated
individual SCN neurons derived from Cry1–/– mice are arrhythmic or only
transiently rhythmic, whereas neurons from Cry2–/– SCN show persistent rhythms
of higher amplitude with longer period lengths than in wild type (14). Similarly,
peripheral tissue explants and cells from Cry1–/– mice are arrhythmic whereas
from Cry2–/– mice are rhythmic with longer period length than wild type (14,20).
The more prominent role of Cry1 is also supported by behavioral phenotypes of
compound knockouts; Cry1+/–:Cry2–/– mice show more persistent rhythms than
Cry1–/–:Cry2+/– mice, and while Per2–/–:Cry2–/– mice are rhythmic, Per2–/–:Cry1–/–
mice are arrhythmic (108,112). Taken together, these studies indicate that Cry1
is required for cellular rhythmicity and plays a more prominent role than Cry2 in
the clock mechanism.
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FIGURE 5. Sequence alignment and key structural features of mCRY1 and mCRY2. mCRY1 and mCRY2
share ~70/80% sequence identity/similarity. Amino acid sequence alignment was generated using Vector NTI
(Invitrogen). Amino acid sequence alignment: blue, identical; green, similar; red, divergent. Secondary structures:
arrow, alpha helix (numbers are assigned based on Arabidopsis UVR3); barrel, beta strand; CC2: coiled coil 2.
FAD-binding residues; gray star, Trp triad; red star.
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Specific Research Objectives–
Aim1: Identification of Sequences That Differentiate Cry1 from Cry2. The
above mentioned knockout studies demonstrated that CRY1 and CRY2 play
different roles in circadian clock function, both at behavioral and at cellular levels.
However, molecular details underlying the functional distinction between the two
mammalian cryptochromes are not well understood. Though CRY1 and CRY2
share 70% identity and 80% homology in amino acid sequences (Fig. 4) and
possess similar biochemical function as a repressor, their genetic perturbation
has opposite effects on clock function. Specifically, CRY1 functions to lengthen
period length of rhythms and is required for persistent cellular rhythms, whereas
CRY2 functions to shorten the period and reduce the amplitude of the rhythm.
A hallmark of circadian clock function is the rhythmic expression of clock
genes, the functional importance of which has been revealed by recent studies.
For example, while the Bmal1 gene is essential, its rhythmic expression is
dispensable for core clock function (113). In contrast, rhythmic expression of
Cry1 is required for cell-autonomous circadian oscillation (48). In addition to the
E/E’-box (responsible for morning-time phase of gene expression, e.g., Reverbα) at the core of the clock mechanism, at least two other circadian ciselements are involved: the DBP/E4BP4 binding element (D-box; day-time phase,
e.g., Per3) and the ROR/REV-ERB binding element (RRE; night-time phase,
e.g., Bmal1). In a recent study, we showed that Cry1 transcription is mediated by
all three circadian elements (i.e., E/E’-box and D-box elements in the promoter
and RREs in the first intron of the Cry1 gene), giving rise to the distinct Cry1
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evening-time phase (48). Further, through genetic complementation, we showed
that this distinctive delayed phase of Cry1 expression is required to restore
circadian rhythmicity in the arrhythmic Cry1–/–:Cry2–/– fibroblasts (48). It is now
known that Cry1 is regulated by a combinatorial transcription mechanism and
strongly rhythmic in most tissues including the SCN, while Cry2 has only weak
rhythms (24,34,48,106,107,114,115).Their differential expression patterns may
partially explain the differential roles in clock function in vivo. Alternatively, CRY1
protein level may be higher than CRY2, or CRY1 may be a stronger repressor
than CRY2.
Based on experimental evidences as summarized above, we hypothesize
that the differential functions of CRY1 and CRY2 lie at the protein and
biochemical levels. In order to understand the genetic and biochemical basis of
their differential functions in the circadian clock, I examined CRY1 and CRY2
function in a genetic complementation assay in which their transcription is under
control of the same promoter and proteins are expressed to similar levels. I took
advantage of the Cry rescue assay to dissect the differential functions of Cry1
and Cry2. First, I confirmed that Cry1 can restore cell-autonomous circadian
rhythms in Cry1–/–:Cry2–/– cells, while Cry2 cannot. Through systematic analyses
of protein domain structure-function relationships, I identified a highly conserved
α-helical domain within the PHR that distinguishes CRY1 from CRY2.
Subsequently, I demonstrated that, contrary to previous speculation, the least
conserved CTD is dispensable for circadian oscillation, but serves to modulate
rhythm amplitude and period length.
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Aim2: Identification of the Biochemical Basis for Differential Functions of
CRY1 and 2. The basic molecular mechanism underlying the circadian negative
feedback loop in mammals was established in the late 1990s (22,116,117), in
which PERs and CRYs were the transcriptional repressors of BMAL1/CLOCK
transcriptional activity. Later on, it was further demonstrated that the feedback
repression is mediated primarily by CRYs, not PERs (24,118). Mutation studies
on Bmal1 and Clock demonstrated that CRY-mediated repression of
BMAL1/CLOCK activity is required for clock function and maintenance of
circadian rhythmicity (119). Although Cry1 and Cry2 have differential transcription
regulation and expression pattern in vivo, which may play roles in their differential
functions, they localize to the nucleus in a synchronous manner through
posttranslational regulation (114). Thus, regulation of subcellular localization is
similar between the two proteins. Therefore, we confirm that the basis for their
differential function lies at the difference in their intrinsic biochemical activity and
not their differential expression pattern.
To understand the biochemical basis of their differential functions, we
performed transcriptional repression assay of CRY1 and CRY2 in Cry deficient
cells under our genetic rescue condition. In these studies, we demonstrated that
CRY1 is a much stronger repressor than CRY2, and repression strength
positively correlates with rhythm amplitude. Thus, our data demonstrate that
CRY1-specific repression is necessary for normal clock function.
In summary, these findings provide, for the first time, the biochemical
basis for differential functions of CRY1 and 2 in the mammalian circadian clock.
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We identified a novel domain within the CRY1’s PHR that is critical for circadian
rhythmicity, and we demonstrated that this domain functionally differentiates
CRY1 from CRY2. We also demonstrated that, the least conserved CTD, which
was speculated to be the differential domain responsible for CRY functions, is not
required for circadian rhythmicity, but plays a key role in regulating the period
length of circadian rhythmicity in mammals. Finally, we identified that differential
transcriptional repression activity is the biochemical basis underlying differential
function, and CRY1-specific repression is critical for circadian rhythmicity.
Overall, our findings shed new light on the functional importance of CRY1PHR(313-426) and the CTD in the clock mechanism.
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MATERIALS AND METHODS
Plasmid Constructions–
Cloning of Cry genes in pMU vector. The Cry1 expression vector, pMU2P(Cry1)-intron-Cry1, was made in a previous study (48). To generate pMU2P(Cry1)-intron-Cry2, the full-length coding region of mouse Cry2 was amplified
using HiFi-DNA polymerase (Invitrogen) with forward primer (5'-TCTAGATGG C
AAACAGCTATTATGGGTATTATGGGTGCGGCGGCTGCTGTGGTG-3';
underline, XbaI restriction site) and reverse primer (5'-GTCGACTGCCATTTCA
TTACCTCTTTCTCCGCACCCGACATAGATTCAGGAG TCCTTGCT-3';
underline, SalI). The PCR product was cloned into pCR2.1-TOPO vector
(Invitrogen) and the digested XbaI/SalI fragment was then sub-cloned into pMU2
vector in place of the Cry1 gene (Fig. 6). For construction of pMU2-P(CMV)-Cry2,
the full-length coding sequence of Cry2 was digested from pMU2-P(SV40)-Cry2
(48) with PI-PspI and PI-SceI, and the Cry2 fragment was cloned into the PIPspI-PI-SceI sites immediately downstream of the CMV promoter.
Domain swapping chimeric constructs. Domain swapping constructs were
generated by overlapping PCR. The primers (Table 1) were designed so that
swap junctions reside in highly conserved or identical sequences, so as to
minimize major structural changes and protein folding problems. Similar to Cry2
cloning, the PCR products were first cloned into pCR2.1-TOPO vector according
to manufacturer’s protocol (Invitrogen). Following cloning into pCR2.1-TOPO
vector, the cloned genes were digested with XbaI/SalI and gel-purified.
Subsequently, the purified fragments were cloned into the XbaI/SalI digested
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FIGURE 6. pMU2-P(Cry1)-Flag-Intron-mCry1 construct. Cry1 gene expression
is driven by Cry1 promoter element (P(Cry1)) and first intron of Cry1 gene (48).
To clone chimeric and mutant constructs into pMU vector, pMU2-P(Cry1)-FlagIntron-mCry1 construct was digested with XbaI and SalI. Digested vector was
ligated with chimeric or mutant sequences digested with XbaI and SalI from
pCR2.1-TOPO vector (Invitrogen).
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pMU2 vector.
Mutant constructs. Site-directed mutagenesis using overlapping PCR was
performed to generate single mutations within the CRY1-PHR(313-426) of CRY*.
The primers (Table 2) were designed in such a way that they already
incorporated the corresponding nucleotide substitutions to achieve expected
mutation. To generate deletion mutant, same overlapping PCR strategy was
employed.
As describe above, all the PCR products were first cloned in pCR2.1TOPO followed by digestion with XbaI/SalI. Subsequently, the digested
fragments were cloned into the pMU2 vector.
Fibroblasts Culture and Real-time Circadian Reporter Assay– Mouse
embryonic fibroblasts (MEF) from Cry1–/–:Cry2–/– double knockout mice; Cry1–/–
:Cry2–/– cells were cultured in DMEM (Hyclone) supplemented with 10% FBS
(Hyclone) and antibiotics (100 U/ml penicillin and 100 mg/ml streptomycin,
Hyclone). Real-time circadian reporter assays were performed using a Lumicycle
luminometer (Actimetrics, Inc.) as previously described (11,48) (Fig. 7). One day
prior to transfection, 4 x 105 cells were plated onto 35 mm culture dishes. Cells
were co-transfected using transfection reagent FuGene6 (120) with 3.95 μg of
pGL3-P(Per2)-dLuc reporter plasmid (119) and 0.075 μg of a Cry expression
plasmid. For the Cry1 dose response experiment, the amount of plasmid was
adjusted to 5.45 μg with empty vector. Three days post-transcription, the medium
was replaced with 1.5 ml of HEPES-buffered (pH 7.2) recording medium
supplemented with B-27 and containing 0.1 mM luciferin, antibiotics and10 μM
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forskolin as previously described (48). Bioluminescence from each dish was
continuously recorded with a photomultiplier tube (PMT) for ~70 sec at intervals
of 10 min at 36˚C. Raw data (counts/sec) were plotted against time (days) in
culture and are presented in the figures.
Analysis of Circadian Rhythm Parameters– For analysis of rhythm
parameters, we used the LumiCycle Analysis program (version 2.31, Actimetrics,
Inc.). Raw data were baseline fitted, and the baseline-subtracted data were fitted
to a sine wave (damped), from which the period was determined. For samples
that showed persistent rhythms, goodness-of-fit of >80% was usually achieved.
Due to high transient luminescence upon medium change, the first cycle was
usually excluded from rhythm analysis. Amplitude of bioluminescence rhythms
was determined as described previously (48). First, a moving average of the
linearly detrended bioluminescence was calculated. The window size of the
moving average was set to half of the estimated period. The moving average was
smoothed by the smoothing spline method, resulting in an amplitude trend, which
was then removed by dividing by the trend curve of the original time series.
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Table 1. Primer list for generation of domain swapping chimeric constructs.
Name of the construct
pMU2-P(Cry1)-Cry1
intron-A1B2C2D2

Round of
PCR
First

Primer sequence
Reaction 1
Reaction 2

Second
pMU2-P(Cry1)-Cry1
intron-A1B1C2D2

First

Reaction 1
Reaction 2

Second
pMU2-P(Cry1)-Cry1
intron-A1B1C1D2

First

Reaction 1
Reaction 2

Second
pMU2-P(Cry1)-Cry1
intron-A2B1C1D1

First

Reaction 1
Reaction 2

Second

f:
r:
f:
r:
f:
r:

ggtagagctgtcaagattac
ctggatgcagatggggttcccttccattttgtcaaa
tttgacaaaatggaagggaaccccatctgcatccag
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg

f:
r:
f:
r:
f:
r:

ggtagagctgtcaagattac
gcctttcagtttgggcagataacgcctaatatagtc
gactatattaggcgttatctgcccaaactgaaaggc
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg

f:
r:
f:
r:
f:
r:

ggtagagctgtcaagattac
caatagacagagtccccggtaccgggaaagctgctgatagat
atctatcagcagctttcccggtaccggggactctgtctattg
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg

f:
r:
f:
r:
f:
r:

ggtagagctgtcaagattac
ctgaacacagatggggttcccctccattcggtcaaa
tttgaccgaatggaggggaaccccatctgtgttcag
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg
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Table 1. Primer list for generation of domain swapping chimeric constructs (contd).
Name of the construct
pMU2-P(Cry1)-Cry1
intron-A2B2C1D1

Round of
PCR
First

Primer sequence
Reaction 1
Reaction 2

Second
pMU2-P(Cry1)-Cry1
intron-A2B1C2D2

First

Reaction 1
Reaction 2
Reaction 3

Second
pMU2-P(Cry1)-Cry1
intron-A1B2C1D1

First

Reaction 1
Reaction 2
Reaction 3

Second

f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
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ggtagagctgtcaagattac
gcctcttaggacaggtaagtaccgccggatgtagtc
gactacatccggcggtacttacctgtcctaagaggc
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
ctgaacacagatggggttcccctccattcggtcaaa
tttgaccgaatggaggggaaccccatctgtgttcag
gcctttcagtttgggcagataacgcctaatatagtc
gactatattaggcgttatctgcccaaactgaaaggc
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
ctggatgcagatggggttcccttccattttgtcaaa
tttgacaaaatggaagggaaccccatctgcatccag
gcctcttaggacaggtaagtaccgccggatgtagtc
gactacatccggcggtacttacctgtcctaagaggc
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg

Table 2. Primer list for generation of site-directed mutations.
Name of the construct

Round of PCR

pMU2-P(Cry1)-Cry1
intron-Cry*-V316I

First

Primer sequence
Reaction 1
Reaction 2

Second
pMU2-P(Cry1)-Cry1
intron- Cry*-K322R

First

Reaction 1
Reaction 2

Second
pMU2-P(Cry1)-Cry1
intron- Cry*-R334K

First

Reaction 1
Reaction 2

Second
pMU2-P(Cry1)-Cry1
intron- Cry*-I372V

First

Reaction 1
Reaction 2

Second
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f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:

ggtagagctgtcaagattac
tgtcccaagggatctggatacagatggggttcccctc
gaggggaaccccatctgtatccagatcccttgggaca
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gccagagcctcggggttgcggtcccaagggatctgaac
gttcagatcccttgggaccgcaaccccgaggctctggc
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
atccacgggaagcctgtcttgccttctgcccatttggc
gccaaatgggcagaaggcaagacaggcttcccgtggat
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
tcccttcttcccagctgacccacaggtcaccacgagt
actcgtggtgacctgtgggtcagctgggaagaaggga
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg

Table 2. Primer list for generation of site-directed mutations (contd).
Name of the construct

Round of PCR

pMU2-P(Cry1)-Cry1
intron- Cry*-E376S

First

Primer sequence
Reaction 1
Reaction 2

Second
pMU2-P(Cry1)-Cry1
intron- Cry*-E382D

First

Reaction 1
Reaction 2

Second
pMU2-P(Cry1)-Cry1
intron- Cry*-W390F

First

Reaction 1
Reaction 2

Second
pMU2-P(Cry1)-Cry1
intron- Cry*-I392V

First

Reaction 1
Reaction 2

Second
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f: ggtagagctgtcaagattac
r: tcccttcttcccagctgacccacaggtcaccacgagt
f: actcgtggtgacctgtgggtcagctgggaagaaggga
r: gtatcttatcatgtctgctcg
f: ggtagagctgtcaagattac
r: gtatcttatcatgtctgctcg
f: ggtagagctgtcaagattac
r: tgcatcaagcagtaactcatcaaagaccttcatccct
f: agggatgaaggtctttgatgagttactgcttgatgca
r: gtatcttatcatgtctgctcg
f: ggtagagctgtcaagattac
r: gtatcttatcatgtctgctcg
f: ggtagagctgtcaagattac
r: acttccagcatttatgctaaaatctgcatcaagcagtaa
f: ttactgcttgatgcagattttagcataaatgctggaagt
r: gtatcttatcatgtctgctcg
f: ggtagagctgtcaagattac
r: gtatcttatcatgtctgctcg
f: ggtagagctgtcaagattac
r: catccaacttccagcattcacgctccaatctgcatcaag
f: cttgatgcagattggagcgtgaatgctggaagttggatg
r: gtatcttatcatgtctgctcg
f: ggtagagctgtcaagattac
r: gtatcttatcatgtctgctcg

Table 2. Primer list for generation of site-directed mutations (contd).
Name of the construct

Round of PCR

pMU2-P(Cry1)-Cry1
intron- Cry*-S404A

First

Primer sequence
Reaction 1
Reaction 2

Second
pMU2-P(Cry1)-Cry1
intron- Cry*-N425S

First

Reaction 1
Reaction 2

Second
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f:
r:
f:
r:
f:
r:
f:
r:
f:
r:
f:
r:

ggtagagctgtcaagattac
aaaattgctgaaaaaaggcactgcaggacagccacat
atgtggctgtcctgcagtgccttttttcagcaatttt
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
cgcctaatatagtctccactgggatctgtcctcctac
gtaggaggacagatcccagtggagactatattaggcg
gtatcttatcatgtctgctcg
ggtagagctgtcaagattac
gtatcttatcatgtctgctcg

FIGURE 7. Work flow for real-time circadian reporter assay. Cry1–/–:Cry2–/–
cells are seeded at a density of 4 x 105 cells / dish, on 35-mm dish, one day prior
to transfection. On day 2, cells are cotransfected with reporter plasmid and
plasmid containing gene of interest. Two days post-transfection, cells are washed
with PBS and freshly prepared recording medium is added before loading them
onto the real-time bioluminescence recording device called LumiCycle.
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Transcription Repression Assay– Cry1–/–:Cry2–/– fibroblasts were grown
and transfected as described above with the following modifications. In
transfection, 1 µg of reporter plasmid, pGL3-P(Per2)-dLuc (119), pGL3-3xE'-boxP(SV40)-dLuc, pGL3-3xE-box-P(SV40)-dLuc, or pGL3-P(SV40)-dLuc (18), was
used together with 2 µg of a Cry expression plasmid. In some assays as
presented in Figures 9 and 16, 0.5 µg each of Bmal1 and Clock plasmid DNA
(121) was also included. Empty vector was used to make up the total amount of
DNA to 4.1 µg per well. As an internal control, 50 ng of a phRL-SV40 plasmid
expressing Renilla Luciferase (RLuc) (Promega) was added in each transfection.
Forty-eight hours after transfection, cells were harvested and assayed with DualLuciferase Reporter Assay System (Promega). Luciferase activity was
normalized by RLuc activity.
For evaluation of correlation between rhythm amplitude and repression
activity, linear fit of a first-order-polynomial was performed by the least square
method. Statistical significance was evaluated by Pearson's correlation. Analysis
was performed using Microsoft Excel or R version 2.8.1.
Immunoblotting– Each Cry construct (1 μg) was co-transfected with either
empty vector (0.4 μg) or Bmal1/Clock (0.2 μg each) in 293T cells or in Cry1–/–
:Cry2–/– fibroblasts in a 12-well plate. Forty-eight hours after transfection, cells
were trypsinized and washed twice with phosphate buffer saline (PBS). Next,
trypsinized cells were collected in 1.5 ml microcentrifuge tubes and lysed in 100
ul RIPA buffer containing 150 mM sodium chloride, 1.0% Triton X-100, 0.5%
sodium deoxycholate, 0.1% SDS (sodium dodecyl sulphate), 50 mM Tris, pH 8.0
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and protease inhibitors. The lysates were cleared by centrifugation at 4˚C,
10,000 rpm for 20 min and supernatants were collected in new tubes for protein
sample preparation. Samples for SDS-PAGE were prepared by adding 6X
loading sample loading dye and boiling for 5 min at 100 ˚C. Proteins samples
were then separated by 12% sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). After separation, proteins were transferred to
polyvinylidene fluoride (PVDF) membrane for immunoblotting. Western blot
analysis was performed with guinea pig polyclonal antibodies against CRY1 or
CRY2 as described previously (24,34,114,122) or against Flag tag according to
manufacturer’s protocol (Sigma). Antibodies used for this study are listed in
Table 3.
Protein structure homology modeling– Homology models for full length
mCRY1 and mCRY2 were generated using the I-TASSER protein structure
prediction server (123-125). This server first threads fragments of the target
sequence to representative PDB structure templates with matched sequence
identity greater than 70%. The fragments are then assembled into a full-length
model while the unmatched regions are built via ab initio modeling. Hence, unlike
other homology modeling software, this server predicts the structure even when
there are no matched sequences in known PDB structures. The quality of
predicted structure was assessed with a scoring method, and five atomistic
models with highest scores were obtained for each input protein sequence.
Images of predicted structures were created using PyMOL software, version
1.2r3pre (Schrödinger, LLC.).
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Table 3. Antibodies used for immunoblotting.

Primary antibody

Secondary antibody

Catalog
number

Source

Dilution

Catalog
number

Source

Dilution

Mouse antiFlag

F3165

Sigma

1:5000

Goat anti-mouse

1858413

Pierce

1:200

Guinea pig
anti-mCry1

—

Lee lab (Lee et
al., Cell, 2001)

1:1000

Rabbit anti-guinea
pig

Lee lab (Lee et
al., Cell, 2001)

1:1000

Guinea pig
anti-mCry2

—

Lee lab (Lee et
al., Cell, 2001)

1:1000

Rabbit anti-guinea
pig

—

Goat anti-βactin

sc-1615

Santa Cruz
Biotech Inc.

1:1000

Donkey anti-goat

sc-2033

—

Lee lab (Lee et
al., Cell, 2001)
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1:1000
Santa Cruz
Biotech Inc.

1:1000

RESULTS
Cry1, But Not Cry2, Can Restore Circadian Clock Function in Cry1–/–
:Cry2–/– Fibroblasts– To confirm the differential functions of Cry1 and Cry2 in
clock function, we first tested their ability to restore circadian rhythms in
otherwise arrhythmic Cry1–/–:Cry2–/– fibroblasts through genetic
complementation and kinetic bioluminescence recording. In this assay,
expression of Cry is under control of a composite Cry1-phase promoter
containing E/E’-box and D-box elements in the promoter and RREs in the first
intron of the Cry1 gene (Fig. 8A).
As expected, Cry1 was able to restore rhythms in these arrhythmic Cry1–/–
:Cry2–/– cells (Fig. 8B), consistent with previous results (48), and the rescued
cells showed longer period lengths than wild type, characteristic of Cry2–/– cells
(14). In contrast, however, Cry2 was unable to restore circadian oscillation to
Cry1–/–:Cry2–/– fibroblasts, confirming results found for cells from Cry1–/– mice
(14) (Fig. 8B). Interestingly, rescue of rhythmicity is largely independent of the
dose of Cry1, ranging from nanograms to micrograms of DNA used in the
transfection (Fig. 8C, left panel). On the other hand, Cry2 of any amount failed to
rescue circadian rhythmicity in these cells (Fig. 8C, right panel). Thus, our data
establish that Cry1 and 2 play differential roles at the level of core clock function:
while Cry1 is essential for generation of cell-autonomous circadian clock function,
Cry2 is dispensable.
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FIGURE 8. Cry1, but not Cry2, restores circadian rhythmicity in arrhythmic
Cry1–/–:Cry2–/– fibroblasts. (A) Schematic representation of expression vectors
and general experimental design. In the Cry expression vector, Cry is under
control of a composite Cry1-phase promoter that contains all three circadian
elements: E-box, D-box from the Cry1 promoter, and RRE from a Cry1 intron.
The reporter vector contains the destabilized Luciferase (dLuc) gene driven by
the Per2 promoter. Transfected Cry1–/–:Cry2–/– fibroblasts are either harvested for
a transcription repression assay, or synchronized for kinetic bioluminescence
recording. (B) Representative bioluminescence records from Cry1–/–:Cry2–/–
fibroblasts expressing Cry1 or Cry2. Genetic complementation of Cry1 (red),
butnot Cry2 (blue), restored circadian rhythms in these cells. Each expression
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FIGURE 8. Cry1, but not Cry2, restores circadian rhythmicity in arrhythmic
Cry1–/–:Cry2–/– fibroblasts (contd.).
construct was cotransfected with the P(Per2)-dLuc into the cells. Three days
posttransfection, the cells were synchronized by forskolin treatment and followed
by bioluminescence recording for 5–6 days. (C) Cry1 of different amounts of
plasmid DNA restored circadian rhythms in Cry1–/–:Cry2–/– fibroblasts.
Experiments were done as in B.

As the Cry expression level in these fibroblasts was below detection limit,
the ability of P(Cry1)-Intron-Cry constructs to express CRY proteins was tested
by Western blot in transfected 293T cells (Fig. 9A). Additionally, to compare their
relative expression in Cry1–/–:Cry2–/– fibroblasts, we determined that 3xFlag-Cry1
and 3xFlag-Cry2 (functionally comparable to Cry1 and Cry2, respectively, in the
rescue assay; Fig. 9B, left panel) are expressed to similar levels in these cells
(Fig. 9B, right panel).
Unlike the high-amplitude rhythmic expression of Cry1 in various tissues
and cells, Cry2 expression is either not rhythmic or rhythmic at very low
amplitude (24,34,114,122). It is thus possible that this differential rhythmic
expression contributes to functional differences in vivo. In our in vitro rescue
assay, the same Cry1-phase promoter is used to control both Cry1 and Cry2
expression, so this strategy eliminates confounding effects of differential
transcriptional regulation. Thus, our data showing that Cry1 (but not Cry2)
restores circadian rhythms in Cry1–/–: Cry2–/– fibroblasts suggest that CRY1 and 2
possess different intrinsic biochemical properties at the protein level that call for
further investigation.
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FIGURE 9. Western blot analysis of CRY proteins. (A) HEK-293T cells were transfected with
different Cry constructs in the absence or presence of Bmal1/Clock as indicated. Total cell extracts
were probed with either anti-CRY1 (left panel) or anti-CRY2 (right panel) antibody. Compared to
CMV promoter, P(Cry1)-Intron drives low levels of protein expression, which can be further induced
by cotransfected Bmal1/Clock to a higher level. Detection of CRY proteins indicates that all Cry
constructs are able to express the proteins. Because the regulation of Cry expression in functional
clock cells (e.g., those that are rescued by P(Cry1)-Intron-Cry1) is different from that in arrhythmic
cells (e.g., those expressing Cry2), to directly compare Cry expression, transfected 293T cells
provide a better means to test these constructs for their ability to express proteins. 3xFlag-CRY1 and
CRY2, positive controls. Arrow, non-specific (NS) band. (B) Cry1 and Cry2 are expressed to similar
levels in Cry1–/–:Cry2–/– fibroblasts in the rescue assay.
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CRY1-PHR(313-426) is Critical for CRY1 Function– To probe the
biochemical origin of the differential functions of CRY1 and 2, we set out to
identify the critical structural region that differentiates the two. Based on known
structure and domain function of PHL/CRY proteins (60,96,126), we divided
CRY1 and 2 proteins into four regions, namely A, B, C and D (Fig. 10). Using an
overlapping PCR strategy, we generated a series of Cry swapping chimeras by
systematically substituting different regions of Cry1 with the corresponding
sequences from Cry2 (Fig. 11A). To minimize major structural changes and
protein folding problems, we selected highly conserved or identical sequences at
swap junctions (Fig. 10). The ability of these chimeras and the mutant Cry
constructs to express CRY proteins was tested by Western blot (Fig. 9). These
chimeras were then tested for their ability to restore circadian rhythms in Cry1–/–
:Cry2–/– fibroblasts. Cry1 chimeras that harbor A, C, or D regions of Cry2 were
able to generate cellular rhythms, suggesting that these regions of Cry1 and 2
have comparable clock function (Fig. 11B). However, when the B region in Cry1
(Cry1-B) is replaced with the corresponding B region of Cry2 (Cry2-B), the
A1B2C1D1 chimera failed to restore rhythms, suggesting that Cry1-B is required
for circadian clock function (Fig. 11C)
To further confirm the role of Cry1-B, we generated a Cry2 chimera,
A2B1C2D2, in which the B region of Cry2 is replaced by the corresponding Cry1B, designated as Cry*. Similar to Cry1, Cry* was also able to generate rhythms,
indicating that the B region of Cry1 is sufficient to render Cry2 able to perform the
role of Cry1 in clock function (Fig. 11C). In fact, all chimeras that harbor Cry1-B
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FIGURE 10. A schematic diagram of domain structure of CRY proteins. To identify a region that differentiates
CRY1 from CRY2, entire protein sequence was divided into four domains: domain A (blue), B (green), C (cyan),
and D (yellow) based on the predicted their predicted structure (126).
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were able to sustain circadian oscillation, while those containing Cry2-B failed to
do so (Fig. 11A). Interestingly, a previous mutagenesis study also hinted that this
region likely differentiates CRY1 and CRY2 (1). Thus, we have identified a critical
region within the highly conserved α-helical domain of CRY1 PHR (from amino
acid 313 to 426) that can differentiate CRY1 from CRY2 and is critically required
for Cry1 function. We name this region as CRY1-PHR(313-426).
Identification of Critical Amino Acid Residues within the CRY1-PHR(313426)– Since the CRY1-PHR(313-426) underlies functional divergence of CRY1
and CRY2, we performed site-directed mutagenesis to identify the critical amino
acid residues. Among the ~100 residues within the CRY1-PHR(313-426), twelve
are divergent between CRY1 and 2 (Fig. 10). Each of the 12 amino acids in Cry*
was mutated to the corresponding residue in Cry2, one or two at a time. Since
these amino acid residues exist naturally in Cry2, major structural changes are
unlikely to occur. We then tested individual mutants for their ability to rescue
rhythms in Cry1–/–:Cry2–/– fibroblasts. Among 12 mutants, six restored circadian
rhythms in these cells, similar to Cry1 and Cry*, whereas the other 6 mutants
failed to do so: Cry*-V316I, K322R, I372V, I392V, S404A (Fig. 12A), indicating
that these six residues within the CRY1-PHR(313-426) are critical for CRY
function in the clock mechanism.
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FIGURE 11. CRY1-PHR(313–426) is critical for Cry1 function. (A) Cry
expression constructs. Cry1 (red) and Cry2 (blue) were divided into four regions:
1) region A includes the N-terminal α/β domain and the inter-loop domain of the
PHR; 2) region B is the CRY1-PHR(313–426) and includes the core α-helical
domain of the PHR (from α13 to α18); 3) region C contains the rest of the αhelical domain, including sequences immediately after α18 and before the CTD
where CC2 resides; and 4) region D is the CTD. For sequence details, see
Figure 10. The chimeras were made by swapping these regions between CRY1
and CRY2. The schematics are drawn to scale; CRY2 has an extended N
terminus, whereas CRY1 has an extended C terminus. Circadian phenotypes are
shown on the right: R, rhythmic; AR, arrhythmic. (B) and (C), representative
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FIGURE 11. CRY1-PHR(313–426) is critical for Cry1 function (contd.).
bioluminescence records from Cry1–/–:Cry2–/– fibroblasts expressing different Cry
chimeras. Domain-swapped chimeras (in B and C) were tested for their ability to
rescue rhythms in Cry1–/–:Cry2–/– fibroblasts as described in the legend to Figure.
8. All the chimeras that contained the B region from Cry1 (B1, red) were able to
restore rhythms (B), implicating the B domain from Cry1 in rhythm generation.
The B region of Cry1 is sufficient to render Cry2 able to generate rhythms.
Chimera A2B1C2D2 (Cry*, green) restored rhythms, but A1B2C1D1 (light blue)
failed to do so (in C), confirming a required role of CRY1-PHR(313–426) in Cry1
function.

Spatial Orientation of Six Critical Residues and Potential Signal
Transduction– We further performed protein homology modeling to determine the
locations of the 6 critical residues in the modeled CRY1 structure. CRY1 and
CRY2 have conserved structures for regions A through C, with a root mean
square deviation (RMSD) less than 2.0 Å among structures predicted by different
programs using different templates. Most homology modeling programs failed to
predict a structure for the CTD, except for I-Tasser, which placed it in many
different orientations, implying intrinsic flexibility for this region. In a model
excluding the CTD, the identified critical residues are all solvent exposed with the
exception of I392 (Fig. 12B), which is located near the FAD-binding cavity. N425
is localized within a loop motif between helix α18 in region B and α19 in region C,
and is potentially involved in protein-protein interactions. The other four residues
(i.e., V316, K322, I372 and S404) are readily available for potential interaction
with the CTD, CC2, or other clock factors. S404 is localized within a recognition
loop between α17 and α18, which is recently implicated in interaction with the
CTD of Drosophila CRY (95).
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FIGURE 12. Identification of critical amino acid residues within the CRY1PHR(313-426). (A) Representative bioluminescence records from Cry1–/–:Cry2–/–
fibroblasts expressing Cry mutants. Within the CRY1-PHR(313–426), there exist
12 distinct amino acid residues that diverge between CRY1 and CRY2. Cry* was
mutated to the corresponding residues in CRY2 as indicated. Six of the CRY*
mutants failed to rescue rhythms, indicating the critical role of the CRY1PHR(313–426) in CRY1 function. (B) three-dimensional homology model
structure of CRY1 without the CTD. The modeling was based on crystal
structures of bacterial photolyase and Arabidopsis (6-4) PHR (UVR3).Region A,
blue; B, CRY1-PHR(313–426), green; and C, cyan. The CTD is not shown. With
the exception of Ile-392 (purple sphere), the other 5 critical residues identified
within the CRY1-PHR(313–426), namely Val-316, Lys-322, Ile-372, Ser-404 (red
spheres), and Asn-425 (pink sphere), are largely solvent exposed. FAD, black
(O, red; N, blue; P, orange).
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The CTD is Not Required for Circadian Rhythmicity– The CTD represents
the least conserved region among the CRYs. It is generally accepted that the
CTD is critical for CRY function (127). To test the functional importance of the
CTD, we generated a Cry1 CTD-deletion construct, Cry1(∆CTD) (Fig. 13A). To
our surprise, Cry1(∆CTD) was able to rescue circadian rhythms in Cry1–/–:Cry2–/–
fibroblasts. Thus, contrary to expectation, our data suggest that the CTD is not
absolutely essential for CRY1 function (Fig. 13A). This result is consistent with a
previous study, which found that CTD is not absolutely required for repression
(1).
A coiled-coil 2 (CC2) motif within the C region, which is immediately
downstream of the CRY1-PHR(313-426) and upstream of the CTD, was
previously implicated in mediating interactions with other clock proteins (127).
Here we show that a larger C-terminal deletion, Cry1(∆CC2-CTD), which lacks
both CC2 and CTD, eliminated Cry1’s ability to maintain rhythmicity (Fig. 13B),
indicating an important role for CC2 in clock function.
The CTD Regulates Period Length of Circadian Rhythms– Although the
CTD of CRY1 is dispensable, rhythms rescued by Cry1(∆CTD) showed
decreased rhythm amplitude compared to rhythms rescued by full-length Cry1
(see later results), suggesting that CTD modulates rhythm amplitude. Also,
interestingly, although Cry1-rescued cells displayed a long period (~27 hr),
characteristic of Cry2–/– cells, when Cry1-CTD is replaced by Cry2-CTD (chimera
A1B1C1D2), the rescued cells displayed shorter period lengths that are
comparable to wild type cells (~24 hr) (Fig. 14A). In fact, among all Cry chimeras
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FIGURE 13. The CTD is dispensable for CRY function. (A) Schematic diagram
of truncation construct Cry1(∆CTD) in which the CTD is deleted (top panel).
Representative bioluminescence records from Cry1–/–:Cry2–/– fibroblasts
expressing different Cry1(∆CTD) (bottom panel). Deletion of CTD did not render
Cry1 unable to generate circadian rhythms, suggesting that the CTD is
dispensable for CRY1 function. Cry1(∆CTD), green. (B) In the truncation
construct, Cry1(ΔCC-CTD) (top panel), both the CTD and the C region containing
CC2 are deleted from the full-length Cry1. This Cry1 truncation mutant failed to
restore cellular rhythms in Cry1–/–:Cry2–/– fibroblasts (bottom panel;
representative bioluminescence records) indicating an important role for CC2
domain in clock function.
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containing the B region of CRY1 (and therefore conferring circadian rhythmicity),
those that contain Cry2-CTD showed a period of ~24 hr, whereas those that
contain Cry1-CTD showed a longer period (~27 hr). Taken together, our data
suggest that although the CTD is dispensable for Cry1 function, it plays important
roles in modulating rhythm amplitude and period length.
Modeling of the CTD– Our homology models for full-length CRY1 and
CYR2 suggested plausible interactions between the CTD and the identified
Cryptochrome differentiating domain involving the above-identified critical
residues. Consistent with previous observations, the CTD assumes flexible
structural configurations (71). Among possible arrangements of the CTD, those
involving interactions with CRY1-PHR(313-426) are energetically favored,
especially interactions with the side chains of V316, K322, I372, and S404
(Fig.14C), each shown to be critical for CRY function. The observation that these
residues reside in critical regions (e.g., I392 and S404) and/or at an interface
(e.g., V316, K322, I372 and S404) available for potential protein-protein
interaction explains why mutating them impairs normal clock function.
Differential Transcriptional Repression Activity of CRY1 and CRY2– In all
our kinetic rhythm assay experiments, we noticed that there were low expression
levels of the P(Per2)-dLuc reporter in rhythmic cells and high levels in arrhythmic
cells (Figures 11-13). In those Cry1–/–:Cry2–/– fibroblasts where rhythmicity was
rescued by Cry constructs, bioluminescence reading (Y-axis) was observed to be
low compared to those cells where rhythmicity was not restored. Lower
bioluminescence readings indicate lower reporter activity, which in turn indicate
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that the repressor activity of Cry constructs on BMAL1/CLOCK transcriptional
activity is higher in rhythmic cells than arrhythmic cells. Therefore, this data
suggested that rhythm amplitude may be related to potency of repression of
BMAL1/CLOCK transcriptional activity. Since cryptochromes are the repressor of
BMAL1/CLOCK transcriptional activity, the observation of differential reporter
activity in rhythmic and arrhythmic cells prompted us to analyze the relationship
between rhythm amplitude and repression activity of cryptochromes more
quantitatively.
Cry1 Exhibits Stronger Repression Activity than Cry2 under Constitutive or
Circadian Promoters– To examine the correlation between rhythm amplitude and
transcriptional repression activity more quantitatively, we measured P(Per2)-dLuc
expression in the presence of Cry1 or Cry2 in transiently transfected, nonsynchronized cells. When assayed under non-rhythmic conditions in which Cry
expression is controlled by a strong, constitutive promoter such as CMV or SV40,
Cry1 and 2 both displayed slightly different but strong levels of repression (Fig.
15), consistent with previous studies (1,24,118,119). To test for differences in
repression activity of CRY1 and CRY2, we measured Cry repression under our
conditions of genetic complementation in Cry1–/–:Cry2–/– fibroblasts, in which Cry
is regulated by the Cry1-phase promoter. Under these conditions, CRY1 still
displayed strong repression on the P(Per2)-dLuc reporter. CRY2, however, did
not repress transcription to the same extent as CRY1, showing a repression
activity 10 times weaker than CRY1 (Fig. 15).
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FIGURE 14. The CTD modulates period length. (A) Schematic diagram of
various Cry constructs, including the truncation construct Cry1(∆CTD) in which
the CTD is deleted. Period length corresponding to each construct is shown on
the right. Mean ± S.D. (error bar) of two independent experiments are shown. (B)
Representative bioluminescence records from Cry1–/–:Cry2–/– fibroblasts
expressing various Cry chimeras. The Cry rescue assay was performed as in
Figure 8B. While the chimeras that contain the CTD from CRY1 (Cry1 and
A2B1C1D1) restored rhythms with a period length of ~27 hr (A), those that
contain the CTD from CRY2 (A1B1C1D2, A1B1C2D2 and Cry*) restored rhythms
with a period length of ~24 hr (A), implicating the CTD in regulating period length.
(C) three-dimensional homology model structure of full-length CRY1. The model
was generated using the I-TASSER protein structure prediction server. Color
scheme: region A, blue; B, CRY1-PHR(313–426), green; C, cyan; and D, CTD,
orange. The CTD assumes a flexible structural configuration, and one of the
predicted orientations is shown. In this configuration, the CTD resides in close
proximity with the core CRY1-PHR(313–426), particularly with the 4 critical
residues (red spheres).
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FIGURE 15. Cry1 exhibits stronger repression activity than Cry2. Dual
luciferase reporter assay in Cry1–/–:Cry2–/– fibroblasts. For Cry1 expression, three
different promoters were tested. Each Cry construct was cotransfected with
P(SV40)-dLuc (control) or P(Per2)-dLuc reporter. A Renilla luciferase (RLuc) was
added in each transfection to normalize transfection efficiency. Under the control
of the Cry1-phase promoter, CRY1 acted as a much more potent repressor than
CRY2. Mean ± S.D. (error bars) of two independent experiments are shown (n =
3 for each experiment).
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Cry1-Mediated Repression is Specific to Circadian E-box Element– This
difference in repression by CRY1 and CRY2 was observed with 3xE-boxP(SV40)-dLuc or 3xE’-box-P(SV40)-dLuc (Fig. 16A), suggesting that this
differential repression is specific to E-box element and independent of reporters
used in the assay. Similar differential repression was also observed when Bmal1
and Clock were co-transfected in these cells (Fig. 16B). Therefore, we conclude
that CRY1 is a much more potent transcriptional repressor than CRY2 when
expressed under control of a Cry1-phase promoter and repression is specific to
BMAL1/CLOCK transcriptional activity.
CRY Transcriptional Repression Positively Correlates with Rhythm
Amplitude– The differential repression data prompted us to analyze the
dependence of rhythm generation on transcriptional repression. To do this, we
determined the repression activity of a subset of Cry chimeras and mutants used
in our rescue studies. Under control of the Cry1-phase promoter, these Cry
constructs showed various strengths of repression activity (Fig. 17). Importantly,
we observed that all the constructs that were able to rescue the rhythms
exhibited stronger repression activities, similar to Cry1, while those that failed to
rescue have much weaker repression, similar to Cry2 (Fig. 17 B). For example,
Cry1 (A1B1C1D1) and chimera A2B1C1D1 exhibited low but similar P(Per2)dLuc expression, indicative of high repression. In contrast, A1B2C1D1 displayed
significantly elevated reporter activity, similar to Cry2. In addition, mutation at
each of the 6 critical residues within the CRY1-PHR(313-426) impaired
repression (Fig. 17C). These results are consistent with reporter activities
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FIGURE 16. Cry1 mediated repression is specific to circadian E-box
element. Dual Luciferase reporter assay in Cry1–/–:Cry2–/– fibroblasts was
performed to test repression activity of Cry1 and Cry2 in the absence (A) or
presence (B) of exogenous Bmal1 and Clock. For Cry expression, three different
promoters were tested: P(CMV), P(SV40) or P(Cry1)-Intron. Each Cry construct
was cotransfected with P(SV40)-dLuc (control) or 3xE'-box-P(SV40)-dLuc or
3xE-box- P(SV40)-dLuc reporter. A Renilla Luciferase (RLuc) was added in each
transfection to normalize transfection efficiency. Under all three promoters,
particularly the Cry1-phase promoter, CRY1 acted as a much more potent
repressor than CRY2 on circadian E-box element. Similar results were obtained
when Bmal1 and Clock are ectopically over-expressed. Mean ± S.D. (error bar)
of two independent experiments are shown (n = 3 for each experiment).
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observed in kinetic recordings (Figures 8, 11-13). Thus, strong repression activity
is highly correlated with the capacity for rhythm generation.
Finally, we asked if repression activity is also correlated with rhythm
amplitude. Using a previously described algorithm (48), we determined the
rhythm amplitude of Cry-rescued circadian oscillations in Cry1–/–:Cry2–/–
fibroblasts (Fig. 18A). We observed that rhythm amplitudes were low when the
repression activities were relatively low; and conversely, rhythm amplitudes were
high when the repression activities were relatively high. For example, compared
to Cry1, Cry1(∆CTD) showed attenuated transcriptional repression and
accordingly lower rhythm amplitude. Overall, repression activity and rhythm
amplitude bear a highly significant positive correlation, with 82% of the variance
in rhythm amplitude explained by strength of Cry transcriptional repression (r2 =
0.82, p < 0.001) (Fig. 18B). Thus, our data suggest that the strong repression
conferred by CRY1, but not CRY2, on BMAL1/CLOCK-mediated transcription is
the key to generating cell-autonomous circadian rhythms.
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FIGURE 17. Strong transcriptional repression activity is highly correlated
with the capacity for rhythm generation. (A) Repression activities of various
Cry chimeras and mutants. Dual luciferase reporter assay was done as in Figure
15. The constructs that rescued rhythms exhibited stronger repression, similar to
Cry1, whereas those that failed to rescue rhythms exhibited much weaker
repression, similar to Cry2. Mean ± S.D. (error bars) of two independent
experiments are shown (n = 3). (B) Representative bioluminescence records
from Cry1–/–:Cry2–/– fibroblasts expressing various Cry chimeras and mutants.
The Cry rescue assay was performed as described in the legend to Figure 8. (C)
Dual Luciferase reporter assay was performed to test repression activity of the
CRY* single amino acid mutants. Each mutant contains a mutation in one of the
6 critical residues within the CRY1-PHR(313-426) of CRY* (as in Figure 12A). All
mutants displayed weak repression (similar to Cry2), corroborating circadian
phenotypes as shown in Figure 12A.
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FIGURE 18. Transcriptional repression positively correlates with rhythm amplitude. (A) Relative amplitudes of
rescued rhythms observed in Figure 17B. Mean ± S.D. (error bar) of two independent experiments are shown (n = 3). (B)
Relative rhythm amplitude (x axis) is plotted against relative repression activity (y axis). Rhythm amplitude bears a positive
correlation with transcriptional repression by various CRYs. Mean ± S.D. (error bar) of two independent experiments are
shown (n = 3).
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DISCUSSION
Unlike hourglass-type timers, oscillator-type timers such as the circadian
clock regulate cyclic processes that repeat upon completion of a cycle. The
mechanism underpinning this circadian oscillation in mammals is an
autoregulatory transcriptional-translational negative feedback loop (22,117), in
which transcriptional repression by the CRYs lies at the heart of this mechanism
(18,24,119). To gain basic understanding of this biochemical mechanism, we
sought to investigate the unique biochemical and structural aspects of the CRYs.
Through a systematic analysis of protein structure-function relationships, we
identified the distinct sequences that distinguish Cry1 function from Cry2, and
demonstrated that Cry1-specific transcriptional (strong) repression is required for
mammalian clock function. This study provides insights into the unique
biochemical and structural properties of CRY1, and presents new opportunities
for future dissection of its precise role in the circadian clock mechanism.
Genetic Complementation of Cry1 in Cry-deficient Cells Provides a
Functional Clock Model for Mechanistic Studies– In a recent study, we identified
the full set of cis-elements responsible for the circadian expression pattern of
Cry1, including primarily the E/E’-box and D-box elements in the promoter and
RREs in the first intron of the Cry1 gene (48). This allowed us to engineer a
synthetic composite promoter that is both necessary and sufficient for
establishing the Cry1-phase. Importantly, through genetic complementation in
Cry1–/–:Cry2–/– fibroblasts, we also demonstrated that Cry1 expression at the
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evening phase is required for generation and maintenance of cell-autonomous
circadian rhythms.
This Cry rescue assay provided us with a unique opportunity to study CRY
function in clock cells and confirmed that Cry1 and Cry2 indeed have differential
functions in clock regulation. This assay also enabled us to uncover for the first
time the different potency in transcriptional repression exhibited by Cry1 and
Cry2, which underlie their differential roles in clock function. In several prominent
structure-function studies in which Cry expression was under a strong
constitutive promoter (1,127-129), CRY protein (likely saturated) was assayed at
steady-state levels, masking differences in repression activity between CRY1
and CRY2. Consistent with this notion, we show that, compared to the stronger
CMV promoter, SV40-driven Cry1 and Cry2 exhibited a more noticeable
difference in transcriptional repression (Fig. 15). In our study, Cry expression,
under the control of the Cry1-phase promoter, is properly connected to the
negative feedback loop involving both the E/E’-box and D-box elements and the
RREs; under this condition, CRY expression levels would not reach saturation.
Sequence and Domain Structural Features that Distinguish CRY1 from
CRY2– In this study we demonstrated that the functional difference between
CRY1 and CRY2 lies primarily at the CRY1-PHR(313-426) and secondarily at the
CTD. Mechanistically, the level of appropriately timed CRY1 repression is the key
to generating robust rhythms. The CRY1-PHR(313-426) is critical for potent
transcriptional repression. We observed a significant positive correlation between
CRY repression activity and amplitude of the rhythms (Fig. 18). As the repression
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activity goes up, so does the amplitude of the rhythms. Thus, from the
evolutionary point of view, it is the elaboration of a new function for the
conserved core domain of CRY that rendered it a core clock component.
Although the CTD is not absolutely required for circadian clock function, it
participates in modulating basic clock function. Compared to wild type CRY1, the
CRY1 chimera harboring the CTD of CRY2 (A1B1C1D2) shortened the period
length (Fig. 14), indicating its role in period length regulation. Compared to
CRY1, CRY* (A2B1C2D2) displayed slightly reduced, but by and large similar
repression activity. Interestingly, however, compared to the full-length CRY1,
CRY1(∆CTD) displayed less transcriptional repression and generated lower
amplitude rhythms, whereas CRY*(∆CTD) exhibited dramatically reduced
repression activity and failed to generate rhythms, similar to CRY2. Thus, our
data suggest that CTD1 and CTD2 (from CRY1 and CRY2, respectively) play
differential roles in fine-tuning the clock function, and that there might be a
mechanism for signal transduction from identified Cryptochrome differentiating
domain to CTD to accomplish the fine-tuning.
However, the mechanism of repression by CRY and potential signal
transduction from the CRY1-PHR(313-426) to the CTD remain unknown. Current
structural data on the CTD are confined to limited proteolysis and qualitatively
interpreted solution NMR spectra (71), confirming predictions that CTD is largely
disordered. A recent study described the crystal structure of full-length
Drosophila CRY in which the CTD is found to interact with the FAD binding core
domain (i.e., region B in our study). The CTD of dCRY contains only 20 residues,
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whereas CTDs of mCRYs are much longer (80-100 residues) and diverge from
dCRY, and thus, structurally more flexible. Our homology models of mCRYs
confirmed the potential for interactions between CTD and the Cryptochrome
differentiating domain. However, future structural and functional studies are
required to elucidate the mechanism of coordinated function of CTD and the
Cryptochrome differentiating domain of CRY proteins.
CRY1-specific Transcriptional Repression is Required for Circadian Clock
Function– The basic concept of a circadian negative feedback loop in mammals
was established in the late 1990s (22,116,117), and feedback repression is
mediated primarily by CRYs, not PERs (24,118). Through studies of Bmal1 and
Clock mutants that interfere with CRY interaction, it was later demonstrated that
CRY-mediated repression of BMAL1/CLOCK activity is required for clock function
and maintenance of circadian rhythmicity (119). A hallmark of circadian clock
function is the rhythmic expression of clock genes. Recently, we demonstrated
that Cry1 expression at the evening-time phase (i.e., not morning- or day-time)
and therefore proper phasing in feedback repression by Cry1 is important for
normal circadian clock function (48). Here we further demonstrate that Cry1specific repression is the key to generating circadian rhythms; Cry1 was able to
rescue the rhythms in Cry1–/–:Cry2–/– fibroblasts, but Cry2 failed to do so. In
addition, Cry1–/– cells are largely arrhythmic, suggesting that endogenous Cry2
alone is unable to support clock function (11,20). Thus, experimental data from
both gain-of-function (this study) and loss-of-function studies in cellular clock
models (11,130), as well as in circadian behavior of composite knockout mice
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(108,112), establish that Cry1 plays a more prominent role in clock function than
Cry2. Despite the essential role of Cry1 in cell-autonomous models, Cry1–/– mice
nevertheless display persistent free-running rhythms (25,108,112). Therefore,
there exists a gap in knowledge as to how transient rhythms in individual Cry1–/–
neurons are organized into coherent rhythms in the SCN.
Future Perspective– Importantly, the mechanism by which CRY1
represses BMAL1/CLOCK complex activity remains elusive. Our findings that
CRY1, but not CRY2, plays an essential role in clock function, and that CRY1
possesses unique biochemical features, especially within the key CRY1PHR(313-426) domain, suggest that Cry1 holds the key to our understanding of
the feedback repression mechanism. A recent study showed that CRY1 and
CRY2 bind to the CLOCK/BMAL1/E-box complex with the same affinity (131).
Thus, it is possible that their functional difference lies at their different intrinsic
repression activities or differential post-translational mechanisms, and future
studies need to focus on the precise biochemical mechanism by which CRYs
repress CLOCK/BMAL1 transcriptional activity. The functional assay established
in this study provides new opportunities for future investigations into CRY1
structure-function relationships. Our findings shed new light on the functional
importance of the CRY1-PHR(313-426) and the CTD in the clock mechanism.
Several previous studies identified a subset of common motifs and sites,
including nuclear localization sequences, coiled coils, phosphorylation sites of
CK1ε, GSK3β, MAP kinase, and AMPK (1,126-129,132-135), and surely
additional motifs remain yet to be identified. The functional significance of these
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various sequences and structural features in CRY function will need to be tested
using the assays developed in this study. These future studies will ultimately
provide important insights into the biology of CRYs and their role in the negative
feedback mechanism, as well as the functional evolution of the PHL/CRY family
of flavoproteins.
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Appendix A- Generation of phase-specific circadian reporter cell lines
The circadian clock is based on a biochemical negative feedback
mechanism (Fig. 2). The core feedback loop consists of transcriptional activators
BMAL1 and CLOCK, and repressors PERs and CRYs, which act on the circadian
E/E'-box enhancer elements to produce rhythmic gene expression (with morning
phase, e.g., Rev-erbα). The core loop regulates and integrates at least two other
circadian cis-elements, the DBP/E4BP4 binding element (D-box; for day phase,
e.g., Per3) and the ROR/REV-ERB binding element (RRE; for night phase, e.g.,
Bmal1) (18). Combinatorial regulation by multiple circadian elements can
generate novel intermediate phases. For example, Cry1 transcription is mediated
by all three circadian elements (i.e., E/E'-box and D-box elements in the promoter
and RREs in the first intron of the Cry1 gene), giving rise to the distinct Cry1
evening-time phase (48). Based on these mechanisms of gene regulation, we
generated four different luciferase reporter constructs in which Luciferase gene is
driven by different circadian elements.
Luciferases were first used in real-time luminescence recording of
circadian gene expression in the early 1990s in plants and cyanobacteria, and
have been commonly used in the mammalian system since 2000 (15,136-139).
Luciferase reporters are generally less toxic and more sensitive than fluorescent
reporters such as GFP, due to much lower background (140). The most
commonly used bioluminescent reporter is firefly (Photinus pyralis) luciferase
(Luc+) constructed in the pGL3 vector series (Promega), in which the coding
region of the native Luc was modified for optimized transcription and translation.
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The combination of firefly luciferase and its highly stable and cell-permeable
substrate, D-luciferin, is ideal for long-term recording. A destabilized Luc (dLuc)
is a modified version of Luc+ with a PEST sequence fused at its C-terminus to
allow for rapid protein degradation. A further improved version, Luc2, is available
in the pGL4 vector series (Promega) with higher and less anomalous expression.
In a recent report, Brazilian click beetle luciferase (ELuc) was shown to exhibit a
much brighter signal than Luc+, suitable for single cell imaging (141).
Many recent studies have taken advantage of the mPER2::LUC fusion
knock-in reporter mouse (11,14,113,136,142-146). This reporter system allows
circadian phenotyping of cells and tissue explants including the SCN. In our
previous studies, we crossed this reporter mouse line with many of the
behaviorally characterized clock gene knockouts and examined the dynamics of
bioluminescence rhythms in SCN, liver and lung explants cultured ex vivo, and in
dissociated SCN neurons and fibroblasts cultured in vitro (14,113,142,145).
These studies allowed us to gain important insights into the molecular details of
clock operation at the cell and organismal levels.
Here we generated four different reporter constructs: P(Per2)-dLuc and
P(Cry1)-dLuc reporters containing both E/E'-box and D-box elements in the
regulatory region (18,147,148); P(Cry1)-Intron-dLuc representing combinatorial
regulation by all three elements (i.e., E/E'-box, D-box, and RRE) (18,48); and
P(Bmal1)-dLuc regulated exclusively by RRE (18,34,113,143). We cloned the
reporter cassettes into a lentiviral vector (pLV7-Bsd). Then, we introduced these
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reporters into 3T3 cells by infecting them with lentivirus to produce the
anticipated distinct phases of reporter expression (Fig. 19).

FIGURE 19. Phase-specific expression of bioluminescence reporters in 3T3
cells. The lentiviral reporter vectors used in this experiment are pLV7-BsdP(Per2)-dLuc, P(Cry1)-dLuc, P(Cry1)-Intron-dLuc, and P(Bmal1)-dLuc. Each
reporter exhibits a distinct phase of oscillation, as indicated by the arrows. While
the Per2 and Cry1 promoters drive peak bioluminescence at morning-day phases
and the Bmal1 promoter at night phase, combinatorial regulation by the P(Cry1)Intron harboring E-box, D-box, and RRE elements confers evening phase of
peak bioluminescence.
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Unlike tissue or animal models, cell-based models are amenable to
genetic and pharmacologic perturbations, and when necessary, also use in highthroughput screening (HTS) formats. Perturbation of gene function can be
achieved by over-expression or RNAi-mediated knockdown. Selective small
molecules can be used to interfere with protein function. Cell-autonomous clock
models have greatly facilitated mechanistic studies. Hogenesch and colleagues
used the 3T3 model to show that feedback repression by CRYs is required for
clock function (119), and the U2OS model to probe the system-level properties of
clock function (149). We employed the Cry1–/–:Cry2–/– fibroblast model derived
from mice to show that delayed feedback repression is necessary for clock
function (48), and the Bmal1–/– fibroblast model to show that Rev-erbα and β play
redundant roles in regulating RRE-mediated rhythmic gene expression, and that
Bmal1 rhythm is not critically required for core clock function (113). Furthermore,
chemical screening in reporter cells allowed identification and/or clarification of
the functions of GSK-3β (period shortening when perturbed) (143), CK1σ and ε
(period lengthening when perturbed) (150), and CK1α12.
In addition to the core feedback loop, the clock mechanism also integrates
diverse signaling and regulatory factors. For identification of additional clock
components and modifiers, cell-autonomous clock models are advantageous
over genetic screening in mice due to the inherent lethality, pleiotropic effects,
and developmental genetic compensation associated with mutant animal models
(151). Cell-based screens, in combination with functional genomics approaches,
have been effectively carried out using high-throughput recording systems to
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screen genome-wide siRNA and shRNA libraries for identification of novel clock
factors (130,152). Similarly, one can employ chemical biological approaches and
screen for diverse small molecules to study their effects on clock function
(143,150,153,154). Although major clock genes and their functions have been
identified, these screens have identified additional components or modifiers that
are involved in regulation or modulation of the clock. Many of these modifiers
represent particular modalities of integrating signal transduction of synchronous
or asynchronous cues (clock inputs). These cellular models are more tractable
for rapid discovery of basic mechanisms, which then provide new entry points for
in vivo validation and exploration. These four cell lines will serve as great
resource to study the basic clock mechanisms in vitro before in vivo validation.
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Appendix B- Mutation of FAD binding sites and Trp triad electron transfer
pathway: consequences on Cry1 function in circadian clock
Mutation analysis of FAD binding sites– The photolyase/cryptochrome
super family of flavoproteins, found from bacteria to humans, use the same
cofactor, FAD, to carry out dissimilar functions (50,51). A second cofactor has
also been identified in some prokaryotic CPD PHRs, which serves as a lightharvesting antenna. From crystal structures of E. coli and Anacystis nidulans
CPD PHRs, binding sites for the second cofactor 5,10-methenyltetrahydrofolic
acid (MTHF) or 8-hydroxy-5-deazaflavin (8-HDF) were identified (155,156).
Photolyases are DNA repair enzymes that revert UV-induced photoproducts into
normal bases to maintain genetic integrity (52). In contrast, CRYs in plants are
blue-light photoreceptors and regulatory proteins that control their growth and
development. Whereas in animals, they regulate biological clocks (60).
Ectopically expressed and purified human CRY1 and CRY2 from HeLa cells
(157), as well as purified recombinant proteins from E. coli (73) were shown to
contain FAD and pterin, presumably in the form of MTHF. However, both
cofactors were found to be present at substoichiometric levels relative to the
apoenzyme, limiting the characterization of their biophysical properties.
Since cryptochromes in mammals are not photoreceptors, rather they play
a central role in the circadian clock, it is important to understand the functional
contribution of the cofactor FAD in mammalian CRY function. Because of the
prominent role CRY1 plays in the circadian clock function, we decided to
examine the requirement of FAD by CRY1 for its function in circadian clock.
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Since it is difficult to purify CRYs with their cofactors at stoichiometric levels
(73,157), we took an indirect approach by employing site-directed mutagenesis
followed by genetic complementation analysis of gene function to test the
requirement of FAD. Recent modeling studies using the known crystal structure
of Arabidopsis (6-4) photolyase demonstrated conserved structural features for
FAD binding in mouse cryptochromes (126). Previously, it was shown that
mutations in the conserved Asp387–Arg358 salt bridge (invariant in all PHL/CRY
family members and positioned to stabilize the FAD radical), resulted in
significant loss in transcriptional repression ability of CRY1 in an in vitro
repression assay (126,158). However, these mutants were not tested in a true
functional rhythm assay.
Here, we generated mutations in the conserved Asp-Arg salt-bridge by
substituting i) Arg with Lys, Asp or Ala (i.e., Cry1R358K, Cry1R358D,
Cry1R358A) and ii) Asp with Asn (Cry1D387N; Cryb-like). In CRY1, Asn393
interacts with the redox-active N5 position of FAD. We also mutated Asn393 to
Asp or Leu (Cry1N393D, Cry1N393L), mimicking insect- or plant-specific CRY,
respectively. These mutants were then tested for their ability to restore circadian
rhythms in Cry1–/–:Cry2–/– fibroblasts.
We found that, while all three Arg mutants were able to restore the
rhythms, D387N substitution (Drosophila Cryb-like) was sufficient to render Cry1
unable to restore the rhythms (Fig. 20A). Our finding from this gain-of-function
assay is consistent with results obtained in the in vitro transcriptional activity in
transfected S2 cells (158). Compared with dCRY in which both R381A and
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D410A (or Cryb) mutants abolished transcriptional repression activity and light
responsiveness, only one mutation D387N of mCRY1 affected its transcriptional
activity (158). Our mutation study also revealed that D387N mutation affected
Cry1 function; however, R358A, R358K and R358D mutations are tolerated for
Cry1 function.
In the case of Asn393 mutations, the key residue interacting with redoxactive FAD, a mixed result was obtained; while N393D mutant was still able to
generate and maintain rhythms in Cry1–/–:Cry2–/– fibroblasts, N393L abolished
CRY1 function in rhythm generation (Fig. 20A).
Taken together, our mutation studies suggest that the FAD salt-bride
partner Asp387 and the key residue Asn393 play important roles for CRY1
function, whereas Arg358 doesn’t. These data can be interpreted in two ways;
i) Cry1 requires FAD as a cofactor for its activity, and mutations at Asp387 (D387N) and Asn-393 (N393L) abolished the ability of CRY1 to bind to FAD,
whereas all Arg-358 mutants and N393D didn’t have obvious adverse effects.
Our data showing that D387N and N393L mutants are not able to establish
rhythms in Cry1–/–:Cry2–/– fibroblasts supports this notion.
ii) As suggested previously (158), it is also possible that D387N and
N393L mutations alter the structure of CRY1 protein and hence affect its
function. Further studies are needed to confirm whether these mutations affect
CRY1 structure or alter FAD binding.
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Trp triad mutation analysis– Photolyases repair UV light-induced
pyrimidine dimers via intermolecular as well as intramolecular redox pathways.
Upon receiving sun light, photolyases get activated through intramolecular redox
pathway. The photoantena MTHF absorbs a blue light photon and then excites
FADH to an excited state, FADH*. Excitation of FADH results in its
photoreduction by an electron transfer to excited FADH* via an internal chain of
three tryptophans (FADH ←Trp-382←Trp-359← Trp-306; designated as Trp
triad). Subsequently, through intermolecular redox pathway, an electron is
transferred from reduced flavin, FADH– to DNA to repair pryrimidine dimers (159161). Several other studies implicated that tryptophans corresponding to the Trp
triad play a role in the regulation of light dependent or independent reactions
mediated by animal cryptochromes (158,162). We set out to investigate whether
Trp triad is involved in mammalian CRY1 function in circadian clock. We
performed mutational analysis of the Trp triad (based on location in the structure,
inside Trp-397 adjacent to FAD, middle Trp-374, and outside Trp-322) (52,126).
We individually mutated these three tryptophans in CRY1 to either tyrosine,
which is structurally different from tryptophan but still capable of electron transfer
(163,164) or alanine, which is structurally different from tryptophan and also
incapable of electron transfer (W397Y/A, W374Y/A and W322Y/A), and then
tested the ability of the mutants to restore rhythms in Cry1–/–:Cry2–/– fibroblasts.
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FIGURE 20. Mutations of FAD binding site and Trp triad and Cry1 function.
A and B, representative bioluminescence records from Cry1–/–:Cry2–/– fibroblasts
expressing Cry1 mutants. A, Cry1 was mutated to obtain mutation in Asp(387)Arg(358) salt-bridge which is positioned to stabilize the FAD radical, as indicated.
Another key residue Asn-393, which interacts with the redox-active FAD N5
position of FAD, was also mutated as indicated. D387N and N393L mutants
failed to rescue the rhythm indicating important role for Cry1 function. B, all trp
triad mutants, except W397A, failed to rescue rhythms.

Even though W397A mutation still retained CRY1 function to support
scillation, the other two mutants, W374A and W322A, failed to restore rhythms in
Cry1–/–:Cry2–/– fibroblasts, suggesting an important role for Trp triad in CRY1
function. Interestingly, even though W397Y, W374Y and W322Y mutants
contained redox-competent tyrosine, they were not able to restore the rhythms.
The inability of these three mutants to restore rhythms in Cry1–/–:Cry2–/–
fibroblasts may be caused by alteration in CRY1 protein structure due to the
mutations. Previous studies suggested that the Trp triad of Drasophila CRY palys
a role in maintaining structural integrity necessary for function, rather than
participating in the photochemistry of animal cryptochromes (158,162). Thus, it is
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possible that our mutations also altered the structure of CRY1 protein, which may
explain why the mutants we tested here are not functionally active to restore
circadian rhythms in Cry1–/–:Cry2–/– fibroblasts. Therefore, at this point it remains
elusive whether Trp triad is required for CRY1 function.
Further studies are needed to confirm the role of Trp triad in structural
integrity of mammalian cryptochromes. If it plays a role in maintaining structural
integrity, different mutation strategy should be employed to maintain structural
integrity of mutants and then test the functionality of the mutants in genetic
complementation assay.
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Appendix C- shRNA-mediated knockdown of Cry genes in U2OS cells
Circadian clocks exist in cell lines cultured in vitro. Much of what we know
about the biochemistry and cell biology of the clock mechanism is based on three
cellular models: 3T3 mouse fibroblasts (18,119), U2OS human osteosarcoma
cells (130,143,149,152), and mouse fibroblasts derived from mice (48,113,154).
Some of these lines have been shown to be amenable to overexpression of DNA
(cDNA) and knockdown of gene by RNA interference (RNAi). These cell lines
have been successfully used to identify new components of many signaling
pathways (for example, see (165-167)). When transfection efficiency is high,
synthetic siRNA can be transiently transfected into cells to knock down gene
expression. However, when transfection is technically difficult, an shRNA
expression vector can be stably transduced into cells via lentiviral infection, so
that shRNA produced by the cell is processed to siRNA for gene knockdown
(KD). Although cumbersome and less reproducible, transiently transfected cells
can also be grown in the continuous presence of antibiotics to generate stable
cell lines. Lentiviral vectors are still preferred because of their stable integration
into the cell's genome, as well as greater efficiency and versatility. The lentiviral
vector system permits efficient delivery and stable integration into the host
genome of both dividing and non-dividing mammalian cells, and therefore is not
limited to certain cell types as in transient transfection.
Recently, the U2OS model has become a preeminent cellular clock model
largely because it meets the key requirements for high-throughput screening of
commercially available human siRNA libraries (e.g., human origin, capable of
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generating robust circadian rhythms). Here we tested the efficiency of shRNA
mediated knockdown of clock genes in U2OS cells. We generated shRNA
against constructs in pLL3.7 Gateway expression vector (113) for knockdown of
Cry1 and Cry2 genes. We then infected two different U2OS reporter cell lines
(P(Per2)-dLuc and P(Bmal1)-dLuc) with lentivirus containing shRNA expression
cassettes.
Knockdown of Cry1 and 2 resulted in opposite phenotype in this human
osteosarcoma cell line. Knocking down Cry1 gene caused shortening of period
length, whereas knocking down Cry2 lengthened the period length of circadian
rhythms. This opposite period length phenotype was independent of the reporter
as similar phenotypes were observed for both P(Per2)-dLuc and P(Bmal1)-dLuc
reporters (Fig. 21). Our knockdown phenotype are consistent with previously
observed knockout phenotypes at cellular, tissue and behavioral levels (14,108),
suggesting that shRNA-mediated knockdown in U2OS can be employed for
studying gene function, in which stable cell lines with KD of a particular gene can
be generated. Stable knockdown cell lines provide an opportunity to perform
different assays with the same source of cells, which is not readily possible for
transiently transfected cells.
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FIGURE 21. shRNA mediated knockdown of Cry genes in U2OS cells. A and
B, (left panel) representative bioluminescence records from P(Per2)-dLuc and
P(Bmal1)-dLucU2OS reporter cells infected with lentivirus containing shRNA
against either Cry1 or Cry2 gene. Period length corresponding to each shRNA is
shown on the right panel. Mean ± S.D. (error bar) of two independent
experiments are shown. Cry2 knockdown results in lengthening of period length
of circadian rhythm and Cry1 knockdown results in shortening.
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